year
review
paper
first
seri
three
review
paper
highlight
relev
articl
publish
respirolog
respiratori
medicin
journal
acut
lung
injuri
interstiti
lung
diseas
ild
sleep
pulmonari
physiolog
outbreak
avian
influenza
pneumonia
east
china
highlight
signific
viru
assort
bird
role
play
transmiss
bird
human
meanwhil
middl
east
respiratori
syndrom
coronaviru
inhabit
bat
mani
year
transmit
human
persontoperson
transmiss
analysi
patient
confirm
infect
show
high
mortal
major
death
due
sever
pneumonia
acut
respiratori
distress
syndrom
ard
novel
coronaviru
infect
show
respiratori
distress
multipl
organ
damag
mortal
around
affect
patient
influenza
viru
infect
still
sever
challeng
public
health
warrant
continu
effort
vaccin
develop
sepsi
also
major
caus
ard
associ
high
mortal
intens
care
unit
patient
recent
studi
show
prolong
hospit
increas
mortal
group
ard
patient
posit
blood
stream
cultur
howev
find
need
investig
larg
group
ard
patient
multipl
site
unlik
tradit
ard
influenzainduc
ard
featur
epitheli
endotheli
injuri
injur
epithelium
endothelium
orchestr
provok
massiv
inflamm
lung
lead
capillari
leakag
eventu
inhomogen
alveolar
flood
alveolar
flood
process
fluid
leakag
activepass
transport
driven
ion
movement
hydrostat
pressur
cystic
fibrosi
transmembran
regul
conduct
shown
particip
alveolar
fluid
transport
capillari
compart
inhibit
chlorid
transport
worsen
lung
injuri
induc
lipopolysaccharid
rodent
model
suggest
inhibit
activ
fluid
transport
may
delay
lung
injuri
recoveri
among
variou
risk
factor
bile
acid
aspir
induc
lung
injuri
cjun
ntermin
kinas
phosphoryl
well
cytosol
phospholipas
product
result
attenu
junction
protein
occludin
zonula
ecadherin
similarli
pseudomona
aeruginosainduc
lung
injuri
model
claudin
significantli
upregul
degre
bronchoalveolar
lavag
claudin
level
associ
lung
injuri
score
result
strongli
suggest
protect
lung
injuri
occur
junction
protein
express
alveolar
epithelium
angiotensinconvert
enzym
ace
play
role
pathogenesi
ard
bronchoalveolar
lavag
sampl
ard
patient
show
increas
decreas
level
cleav
angiotensin
ii
form
angiotensin
cleav
angiotensin
form
angiotensin
ii
angiostatin
inhibitor
reduc
lung
injuri
lipopolysaccharideinduc
mous
model
suggest
imbal
ace
express
ard
potenti
therapi
downregul
differ
manoeuvr
develop
quantifi
lung
oedema
extravascular
lung
water
guid
manag
ard
recent
studi
use
comput
tomographi
imag
show
inhomogen
distribut
lung
injuri
ard
patient
level
inhomogen
associ
mortal
chest
ultrasound
appli
ard
quantifi
lung
oedema
bline
subpleur
consolid
measur
imag
techniqu
provid
addit
inform
lung
water
may
help
clinic
evalu
manag
fluid
administr
mechan
ventil
set
low
tidal
volum
mlkg
ventil
strategi
shown
reduc
mortal
ard
even
lower
tidal
volum
provid
addit
benefit
recent
studi
show
ventil
mlkg
combin
extracorpor
remov
significantli
increas
ventil
free
day
sever
hypox
patient
prone
posit
ventil
shown
improv
surviv
sever
ard
although
protocol
might
applic
medic
centr
regard
ventil
mode
adapt
support
ventil
equival
volum
control
ventil
mortal
patient
ard
consist
previou
report
lung
eventu
heal
organderiv
stem
cell
mobilizationrepopul
tissu
regener
exogen
stem
cell
extens
studi
differ
lung
injuri
anim
model
test
efficaci
administr
rout
underli
mechan
far
known
exogen
stem
cell
heal
lung
injuri
engraft
paracrin
secret
immun
modul
growth
factor
product
antibiot
peptid
synthesi
pathway
far
ongo
clinic
trial
assess
stem
cell
therapi
number
respiratori
condit
consid
target
stem
cell
treatment
includ
ard
chronic
progress
diseas
idiopath
pulmonari
fibrosi
ipf
chronic
obstruct
pulmonari
diseas
copd
outcom
trial
known
next
year
bronchiectasi
character
viciou
cycl
chronic
purul
airway
inflamm
bronchodil
neutrophil
play
import
role
airway
inflamm
activ
neutrophil
studi
idiopath
bronchiectasi
control
patient
result
show
similar
respons
neutrophil
granulocyt
macrophagecoloni
stimul
factor
two
group
suggest
neutrophil
phagocytosi
gener
oxid
speci
preserv
bronchiectasi
patient
although
exhal
condens
may
detect
differ
macrolid
antibiot
includ
azithromycin
shown
benefici
reduc
symptom
exacerb
underli
mechan
thought
biofilm
disrupt
help
antibiot
penetr
suppress
activ
airway
inflamm
chronic
fibrot
ild
encompass
rang
condit
includ
ipf
connect
tissu
diseaseassoci
ild
gain
increas
promin
last
year
follow
emerg
effect
therapi
pirfenidon
rituximab
despit
rise
clinic
trial
activ
pathobiolog
fibrot
lung
diseas
remain
poorli
understood
develop
ipf
previous
link
abnorm
lymphat
drainag
lymphangiogenesi
data
present
respirolog
egashira
et
al
differenti
distribut
lymphat
drainag
upper
lower
region
lung
particular
interest
research
tri
understand
develop
fibrot
lung
diseas
egashira
colleagu
observ
lymphat
drainag
upper
lobe
follow
bronchovascular
distribut
lower
lobe
lymphat
tend
found
subpleur
region
differ
may
go
way
explain
typic
pattern
distribut
fibrosi
individu
ipf
merit
investig
context
fibrot
ild
cigarett
smoke
recogn
risk
factor
develop
rang
ild
includ
ipf
respiratori
bronchiolitisild
desquam
interstiti
pneumon
activ
smoke
also
associ
increas
risk
develop
ild
individu
rheumatoid
arthriti
furthermor
increasingli
recogn
ild
develop
signific
subset
individu
emphysema
explor
link
cigarett
smoke
ild
emphysema
antoni
et
al
compar
highresolut
comput
tomographi
scan
individu
ipf
raild
copd
author
found
emphysema
signific
proport
patient
ipf
raild
respect
interestingli
compar
individu
copd
ild
emphysema
significantli
lower
packyear
smoke
histori
although
requir
prospect
valid
observ
suggest
emphysema
pulmonari
fibrosi
share
pathogenet
mechan
individu
fibrot
ild
especi
ipf
demonstr
highli
variabl
rate
diseas
progress
make
challeng
clinician
accur
convey
inform
regard
prognosi
point
patient
diagnos
condit
patient
earli
diseas
preserv
lung
function
determin
prognosi
especi
challeng
kondoh
et
al
demonstr
case
individu
advanc
diseas
typic
comput
tomographi
appear
usual
interstiti
pneumonia
extent
honeycomb
identifi
individu
high
risk
earli
progress
ipf
previous
shown
profus
fibroblast
foci
seen
surgic
lung
biopsi
predict
subsequ
diseas
progress
studi
subject
harada
et
al
extend
observ
demonstr
extent
fibroblast
foci
surgic
lung
biopsi
correl
diseas
sever
subsequ
progress
ipf
fibrot
nsip
interest
find
lack
clinic
util
requir
biopsi
materi
serum
marker
make
attract
target
biomark
develop
ild
eas
repeat
sampl
inokoshi
et
al
explor
potenti
extracellular
matrix
compon
hyaluronan
diagnost
prognost
biomark
chronic
fibrot
ild
studi
subject
hyluronan
elev
compar
healthi
control
rose
individu
undergo
acut
exacerb
procalcitonin
small
circul
amino
acid
precursor
calcitonin
investig
marker
bacteri
pneumonia
nagata
et
al
shown
procalcitonin
level
may
use
discrimin
acut
exacerb
ipf
level
remain
low
bacterialdriven
episod
ard
pneumonia
procalcitonin
level
markedli
elev
observ
howev
requir
valid
larg
prospect
cohort
patient
sarcoidosi
remain
enigmat
multifacet
condit
unknown
aetiolog
number
group
previous
report
neg
correl
activ
cigarett
smoke
develop
sarcoid
hattori
et
al
sought
assess
relationship
sarcoidosi
cigarett
smoke
japan
contrast
studi
undertaken
found
strikingli
high
rate
smoke
sarcoid
patient
men
women
smoke
common
sarcoid
patient
agematch
control
almost
decil
age
apart
men
interestingli
hattori
colleagu
note
trend
toward
increas
parenchym
involv
sarcoid
patient
smoke
compar
never
smoke
data
thought
provok
need
caveat
fact
studi
retrospect
reli
smoke
preval
data
gener
japanes
popul
drawn
separ
conduct
research
suchankova
et
al
undertook
studi
myeloid
cell
isol
bronchoalveolar
lavag
patient
sarcoid
explor
express
pattern
trigger
receptor
express
myeloid
two
receptor
belong
immunoglobulin
superfamili
play
role
innat
immun
respons
infect
act
drive
cell
fusion
granuloma
format
trigger
receptor
express
myeloid
express
increas
cell
surfac
bronchoalveolar
lavag
cell
sarcoid
compar
bronchoalveolar
lavag
cell
isol
individu
form
ild
observ
support
role
infect
trigger
develop
sarcoid
also
suggest
trigger
receptor
express
myeloid
express
level
might
effect
biomark
discrimin
individu
sarcoidrel
ild
ild
caus
rare
orphan
lung
diseas
often
overlook
medic
literatur
yet
strike
treatment
advanc
last
decad
come
ultrarar
diseas
insight
deriv
rare
diseas
often
reveal
diseas
mechan
contribut
understand
common
disord
respirolog
publish
stateoftheart
review
treatment
option
pulmonari
alveolar
proteinosi
paper
leth
et
al
explor
detail
current
understand
regard
role
granulocyt
macrophagecoloni
stimul
factor
autoantibodi
key
pathogenet
mechan
major
individu
pulmonari
alveolar
proteinosi
complementari
role
play
novel
therapeut
whole
lung
lavag
disord
increasingli
recogn
last
year
immunoglobulin
diseas
condit
character
rais
serum
multiorgan
deposit
plasma
cell
associ
fibrosi
good
therapeut
respons
corticosteroid
becom
increasingli
clear
result
number
specif
pulmonari
abnorm
matsui
et
al
provid
excel
overview
constel
lung
manifest
larg
case
seri
individu
lung
involv
frequent
observ
find
mediastin
adenopathi
thicken
perilymphat
interstitium
intralobular
septa
proport
case
subpleur
peribronchovascular
consolid
appar
lymphat
spread
diseas
resembl
appear
pulmonari
lymphoprolif
diseas
author
emphas
import
obtain
histolog
confirm
suspect
case
lung
diseas
oblit
bronchiol
extrem
debilit
condit
associ
wide
rang
underli
factor
includ
transplant
reject
autoimmun
diseas
viral
infect
occup
exposur
mechan
divers
condit
lead
develop
oblit
bronchiol
remain
unknown
hashimoto
et
al
sought
understand
environment
exposur
sauropu
androgyn
veget
commonli
eaten
thailand
result
individu
develop
oblit
bronchiol
aqueou
fraction
sauropu
androgyn
extract
trigger
cytokin
releas
monocyt
releas
proinflammatori
cytokin
tumour
necrosi
increas
sauropu
androgyn
extract
monocyt
healthi
control
increas
even
monocyt
deriv
individu
androgynousinduc
oblit
bronchiol
observ
suggest
host
environment
factor
import
develop
oblit
bronchiol
recent
year
seen
increas
number
public
highlight
associ
sleepdisord
breath
cardiovascular
disord
hypertens
heart
failur
stroke
left
untreat
sever
obstruct
sleep
apnoea
osa
associ
increas
risk
prematur
cardiovascular
death
review
evid
regard
potenti
earli
effect
intervent
prevent
possibl
even
revers
alter
endotheli
function
associ
sleepdisord
breath
discuss
addit
oxid
stress
produc
apnoeic
episod
larg
neg
pressur
gener
inspiratori
effort
close
airway
creat
mechan
stress
tissu
thorax
kawano
et
al
test
hypothesi
osa
could
lead
pulmonari
arteri
dilat
studi
patient
suspect
osa
independ
associ
sever
osa
increas
right
descend
pulmonari
arteri
diamet
found
addit
cardiovascular
consequ
number
studi
demonstr
associ
osa
metabol
dysfunct
howev
whether
osa
independ
risk
factor
develop
type
ii
diabet
remain
unclear
metaanalysi
six
prospect
cohort
studi
wang
colleagu
found
statist
signific
associ
moderatetosever
osa
diabet
risk
increas
greater
osa
sever
date
degre
treatment
osa
reduc
risk
yet
firmli
establish
although
result
effect
pap
treatment
glycem
control
patient
type
diabet
studi
trial
help
address
question
wide
rang
neurocognit
impair
also
associ
osa
like
aris
effect
sleep
fragment
intermitt
hypoxia
howev
domain
cognit
affect
osa
extent
improv
achiev
continu
posit
airway
pressur
cpap
easili
discern
due
wide
rang
neuropsycholog
test
employ
buck
colleagu
sought
address
issu
undertak
metareview
five
elig
metaanalys
review
osa
found
associ
deficit
attent
vigil
delay
verbal
visual
longterm
memori
visuospati
abil
execut
function
treatment
cpap
like
improv
attentionvigil
global
cognit
function
data
recent
publish
random
shamcontrol
trial
cpap
nearli
particip
osa
period
found
activ
cpap
signific
effect
object
subject
sleepi
howev
one
three
neurocognit
domain
test
show
betweengroup
differ
even
differ
transient
execut
function
better
cpap
arm
month
differ
greatest
sever
osa
major
issu
kushida
studi
high
intellectu
abil
lack
baselin
cognit
impair
particip
studi
highlight
buck
et
al
cognit
reserv
select
control
pose
signific
obstacl
interpret
data
area
increas
obes
contribut
higher
preval
rate
osa
accumul
evid
health
consequ
untreat
diseas
given
rise
greater
interest
develop
test
simplifi
model
care
screen
assess
treat
osa
comprehens
review
chaicoetz
et
al
provid
excel
synthesi
data
concern
ambulatori
model
care
osa
costeffect
potenti
limit
paper
also
rais
interest
issu
around
role
nonsleep
physician
manag
osa
ioachimescu
teodorescu
provid
thoughtprovok
review
current
literatur
concern
relationship
obstruct
lung
diseas
copd
asthma
osa
term
overlap
gener
appli
coexist
osa
copd
similar
relationship
exist
asthma
osa
given
difficulti
time
clearli
distinguish
copd
asthma
base
clinic
function
criteria
author
put
forward
strong
argument
incorpor
obstruct
lung
diseas
osa
gener
classif
obstruct
lung
diseas
osa
increas
obes
rate
worldwid
along
interrel
relationship
disord
author
emphas
import
identifi
osa
patient
lung
diseas
vice
versa
order
better
understand
respons
therapi
improv
diseas
control
autotitr
cpap
devic
avail
determin
effect
therapeut
pressur
fix
cpap
ongo
longterm
home
manag
patient
osa
year
howev
concern
earlier
work
differ
algorithm
use
variou
manufactur
may
affect
efficaci
devic
control
apnoea
snore
damiani
colleagu
evalu
effect
two
autotitr
cpap
devic
driven
differ
flowbas
algorithm
determin
therapeut
pressur
fix
cpap
devic
test
author
gave
similar
pressur
recommend
well
provid
signific
similar
improv
sleep
breath
one
purport
advantag
autotitr
cpap
lower
mean
overnight
pressur
may
deliv
patient
benefici
term
pressur
toler
sideeffect
howev
luo
colleagu
found
chines
popul
pressur
deriv
autotitr
consist
greater
determin
manual
titrat
identifi
author
may
reflect
greater
sensit
flow
sensor
within
autotitr
cpap
devic
detect
respond
flow
limit
compar
thermistor
use
manual
titrat
studi
damiani
et
al
highlight
need
longterm
studi
evalu
whether
clinic
import
outcom
differ
exist
differ
devic
approach
titrat
although
highli
efficaci
cpap
therapi
toler
accept
longterm
treatment
signific
number
patient
osa
mind
anandam
et
al
undertook
larg
observ
studi
patient
sever
osa
apnoeahypopnoea
index
follow
median
period
year
patient
initi
receiv
cpap
although
continu
therapi
studi
period
anoth
patient
switch
mandibular
advanc
splint
ma
declin
intervent
control
group
individu
apnoeahypopnoea
index
follow
time
period
cumul
cardiovascular
mortal
cpapand
mastreat
group
similar
control
group
mortal
three
group
significantli
lower
untreat
sever
osa
group
howev
differ
mortal
patient
treat
cpap
ma
seen
even
though
patient
treat
ma
higher
residu
apnoeahypopnoea
index
compar
cpaptreat
individu
vs
p
observ
result
studi
consist
find
recent
random
trial
compar
ma
cpap
therapi
patient
full
spectrum
osa
sever
anandam
studi
shortterm
health
outcom
similar
despit
residu
event
higher
mastreat
group
discuss
editori
vanderveken
similar
outcom
two
therapi
like
aris
higher
complianc
ma
offset
lower
efficaci
date
major
limit
ma
inabl
object
monitor
complianc
howev
chang
recent
develop
microsensor
technolog
permit
chip
embed
within
devic
enabl
accur
usag
monitor
although
osa
common
find
major
patient
obes
hypoventil
syndrom
cpap
univers
success
improv
sleepdisord
breath
popul
salord
et
al
provid
use
clinic
insight
resolut
sleepdisord
breath
patient
mildtomoder
oh
factor
could
use
predict
like
fail
cpap
therapi
lower
overnight
oxygen
satur
optim
cpap
first
treatment
higher
partial
arteri
carbon
dioxid
concentr
month
use
measur
detect
poor
respond
follow
month
therapi
interest
find
studi
progress
improv
paramet
studi
period
confirm
result
earlier
random
studi
show
initi
incomplet
respond
cpap
may
improv
time
respirolog
publish
two
excel
review
area
sleep
breath
first
roux
discuss
relationship
restless
leg
syndrom
sleepdisord
breath
provid
comprehens
overview
effect
treat
restless
leg
osa
vice
versa
paper
yamanaka
sadikot
outlin
impact
opioid
use
highlight
widespread
effect
drug
respiratori
system
sleepdisord
breath
includ
immun
cell
function
airway
reactiv
pulmonari
vasculatur
increas
use
opioid
commun
review
time
remind
sideeffect
drug
beyond
caus
respiratori
system
depress
final
wang
colleagu
use
mous
model
demonstr
differenti
effect
hypercapnia
synthesi
neuropeptid
involv
regul
sleep
breath
part
investig
osa
focus
hypoxia
futur
studi
examin
role
peptid
respons
hypercapnia
human
may
shed
light
pathogenesi
osa
lung
function
test
alway
central
diagnosi
treatment
respiratori
diseas
similar
continu
consider
research
focu
ongo
drive
improv
refer
valu
spirometri
necessarili
case
less
common
lung
function
measur
koch
et
al
highlight
mani
predict
valu
static
lung
volum
determin
approxim
year
ago
chang
technic
equip
ie
lung
volum
measur
ga
volum
vs
bodi
plethysmograph
birth
cohort
effect
lack
refer
data
elderli
present
number
limit
exist
equat
koch
associ
collect
plethysmographi
data
static
lung
volum
airway
resist
healthi
nonobes
individu
age
provid
predict
equat
measur
find
demonstr
current
exist
equat
gener
underestim
lung
volum
support
need
contemporari
refer
data
american
thorac
societi
european
respiratori
societi
guidelin
pulmonari
function
test
differ
recommend
regard
bronchodil
effect
singl
breath
diffus
capac
carbon
monoxid
dlco
yang
et
al
report
salbutamol
effect
dlco
normal
individu
fix
airway
obstruct
howev
revers
airway
diseas
salbutamol
increas
alveolar
ventil
decreas
transfer
coeffici
carbon
monoxid
mean
chang
dlco
differ
furthermor
small
group
individu
signific
revers
demonstr
consider
reduct
dlco
salbutamol
better
understand
chang
lung
function
complex
diseas
individu
unabl
perform
tradit
pulmonari
function
test
ie
infant
altern
form
pulmonari
function
test
consider
util
raoufi
et
al
develop
two
nonlinear
model
name
artifici
neural
network
adapt
neurofuzzi
infer
model
estim
respiratori
volum
base
thoracoabdomin
breath
movement
nonlinear
model
report
fit
spirometri
volum
curv
significantli
better
linear
model
particularli
asynchron
breath
may
use
condit
asthma
accur
quantifi
variabl
ventil
prolong
respiratori
monitor
anoth
studi
util
computer
assess
tracheal
forc
expiratori
nois
time
expos
hidden
bronchial
obstruct
individu
high
probabl
bronchial
asthma
acoust
forc
expiratori
nois
time
ratio
height
bodi
mass
chest
circumfer
abl
reveal
acoust
featur
bronchial
obstruct
patient
spirometri
neg
asthma
find
support
forc
expir
nois
time
promis
techniqu
diagnos
hidden
obstruct
reveal
spirometri
laryng
dysfunct
area
pulmonari
diseas
current
underresearch
consist
spectrum
condit
includ
chronic
refractori
cough
globu
pharyngeu
paradox
vocal
cord
movement
muscl
tension
dysphonia
laryng
dysfunct
strongli
associ
condit
atop
asthma
nasal
diseas
masquerad
difficult
treat
asthma
import
studi
vertigan
et
al
provid
novel
inform
regard
condit
associ
laryng
dysfunct
associ
abnorm
laryng
sensat
consider
overlap
sensori
dysfunct
author
believ
find
potenti
indic
similar
mechanist
pathway
may
implic
sensori
neural
dysfunct
patient
condit
grow
recognit
associ
reduc
lung
function
advers
cardiovascular
event
pearc
et
al
investig
associ
fibrinogen
cofactor
platelet
aggreg
major
determin
atherogenesi
lung
function
individu
newcastl
thousand
famili
birth
cohort
mean
age
year
author
report
signific
invers
associ
lung
function
plasma
fibrinogen
concentr
even
control
birthweight
control
gestat
age
sex
breastfeed
durat
total
pack
year
smoke
bodi
mass
index
howev
associ
lost
control
per
cent
bodi
fat
instead
bodi
mass
index
find
interest
consider
prospect
research
need
tri
teas
complex
interact
lung
function
system
inflamm
confound
role
adipos
mmode
ultrasonographi
start
use
extens
noninvas
assess
respiratori
muscl
function
especi
critic
care
set
soilemezi
et
al
util
mmode
ultrasonographi
assess
diaphragm
kinet
healthi
volunt
without
addit
acut
inspiratori
resist
load
addit
inspiratori
resist
decreas
respiratori
rate
increas
tidal
volum
associ
reduct
veloc
diaphragmat
contract
diaphragmat
excurs
chang
observ
mouthpiec
nose
clip
author
suggest
distinguish
chang
diaphragm
motion
inspiratori
load
may
make
diaphragm
ultrasonographi
use
condit
upper
airway
obstruct
consider
bodi
literatur
look
specif
train
respiratori
muscl
tri
improv
function
statu
athlet
perform
varieti
popul
recent
metaanalysi
illi
et
al
conclud
respiratori
muscl
train
improv
endur
exercis
perform
healthi
individu
greater
improv
less
fit
subject
sport
longer
durat
edward
compar
effect
week
respiratori
muscl
train
versu
placebo
breath
vs
maxim
inspiratori
effort
respect
report
chang
lung
function
peak
oxygen
consumpt
either
group
howev
time
volit
exhaust
increment
treadmil
test
veloc
peak
oxygen
consumpt
increas
respiratori
muscl
train
postul
author
perform
improv
may
due
reduc
effort
percept
follow
respiratori
muscl
train
allow
subject
toler
higher
intens
exercis
longer
caus
pulmonari
arteri
hypertens
poorli
understood
condit
associ
vascular
remodel
due
excess
cell
prolifer
reduc
rate
apoptosi
improv
understand
patholog
pah
may
improv
earli
diagnosi
lead
better
treatment
devast
diseas
two
studi
respirolog
made
signific
contribut
understand
pathophysiolog
complex
condit
kabata
et
al
report
preval
mutat
gene
bone
morphogenet
protein
receptor
type
receptor
associ
abnorm
prolifer
pulmonari
vascular
smooth
muscl
cell
endotheli
cell
dysfunct
similar
japanes
patient
pah
compar
report
popul
furthermor
longterm
surviv
pah
unaffect
mutat
statu
contrast
edward
et
al
investig
chang
peripher
lymphocyt
patient
idiopath
pah
connect
tissu
diseas
associ
ph
compar
healthi
control
correl
chang
transplant
free
surviv
studi
demonstr
defici
level
cytotox
tlymphocyt
natur
killer
cell
patient
pah
associ
increas
risk
death
author
suggest
larger
studi
need
investig
phenotyp
cell
differ
diseas
sever
explor
potenti
therapi
number
valid
instrument
avail
assess
health
statu
predict
mortal
guid
health
care
patient
respiratori
diseas
two
recent
addit
group
measur
tool
copd
assess
test
measur
health
statu
simplifi
acut
physiolog
score
develop
predict
mortal
critic
ill
patient
two
origin
studi
respirolog
year
kon
colleagu
report
copd
assess
test
respons
pulmonari
rehabilit
respiratori
diseas
patient
without
copd
correl
differ
domain
valid
chronic
respiratori
diseas
questionnair
support
practic
altern
tradit
measur
contrast
lim
et
al
demonstr
gener
australasia
simplifi
acut
physiolog
score
show
poor
calibr
defin
agreement
individu
probabl
actual
prognosi
outcom
korean
intens
care
unit
patient
howev
util
data
initi
develop
cohort
custom
questionnair
show
good
discrimin
calibr
clearli
demonstr
predict
model
need
custom
use
within
differ
region
world
patient
respiratori
diseas
risk
hypoxaemia
especi
period
increas
metabol
demand
exercis
consider
need
accur
measur
arteri
oxyhaemoglobin
satur
wilson
colleagu
compar
simultan
oxyhaemoglobin
satur
use
puls
oximetri
measur
forehead
finger
patient
copd
desatur
exercis
valu
compar
arteri
capillari
sampl
measur
treadmil
walk
author
demonstr
compar
arteri
sampl
lower
higher
finger
forehead
oximetri
respect
author
correctli
state
arteri
capillari
blood
commonli
slightli
lower
oxygen
arteri
valu
suggest
forehead
measur
like
accur
howev
arteri
sampl
measur
definit
answer
ascertain
nevertheless
data
import
suggest
consider
need
standard
sensor
type
comparison
centr
patient
accur
made
number
potenti
way
predict
extent
hypoxaemia
patient
may
experi
air
flight
gold
standard
current
hypox
inhal
test
hit
expos
patient
similar
inspir
fraction
oxygen
experienc
regular
aircraft
cabin
howev
hit
avail
special
pulmonari
function
test
laboratori
readili
avail
mani
patient
respiratori
diseas
would
like
travel
ling
et
al
assess
whether
oxyhaemoglobin
satur
hit
associ
measur
rest
follow
min
step
exercis
vital
capac
andor
dlco
patient
respiratori
diseas
exercis
correl
hit
report
better
predictor
hit
rest
spirometr
lung
function
variabl
dlco
util
multipl
linear
regress
ling
et
al
present
equat
incorpor
forc
vital
capac
well
rest
postexercis
could
use
predict
hit
special
test
avail
